7151 - 7175 of 7730 Results
Title
Year
-
RESTRICTEDTitle: Screening for Novel LRRK2 Inhibitors Using a High-Throughput TR-FRET Cellular Assay for LRRK2 Ser935 PhosphorylationJournal Name: PLoS ONEPublisher: Public Library of Science (PLoS)Vol: 7Issue #: 8Start Page: e43580End Page: e43580Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1371/journal.pone.0043580Best OA location URL: https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0043580&type=printableCitation Count: 36
-
RESTRICTEDTitle: Caffeine and risk of Parkinson's disease in a large cohort of men and womenJournal Name: Movement DisordersPublisher: WileyVol: 27Issue #: 10Start Page: 1276End Page: 1282Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.25076Best OA location URL: https://europepmc.org/articles/pmc3554265?pdf=renderCitation Count: 153
- Creation of an Open-Access, Mutation-Defined Fibroblast Resource for Neurological Disease Research2012RESTRICTEDTitle: Creation of an Open-Access, Mutation-Defined Fibroblast Resource for Neurological Disease ResearchJournal Name: PLoS ONEPublisher: Public Library of Science (PLoS)Vol: 7Issue #: 8Start Page: e43099End Page: e43099Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc0DOI - Digital Object Identifier: 10.1371/journal.pone.0043099Best OA location URL: https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0043099&type=printableCitation Count: 41
-
RESTRICTEDTitle: Sham surgery controls in Parkinson's disease clinical trials: Views of participantsJournal Name: Movement DisordersPublisher: WileyVol: 27Issue #: 11Start Page: 1461End Page: 1465Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.25155Best OA location URL: https://europepmc.org/articles/pmc3703438?pdf=renderCitation Count: 19
- Roles of Education and IQ in Cognitive Reserve in Parkinson’s Disease-Mild Cognitive Impairment2012RESTRICTEDTitle: Roles of Education and IQ in Cognitive Reserve in Parkinson’s Disease-Mild Cognitive ImpairmentJournal Name: Dementia and Geriatric Cognitive Disorders ExtraPublisher: S. Karger AGVol: 2Issue #: 1Start Page: 343End Page: 352Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-ncDOI - Digital Object Identifier: 10.1159/000341782Best OA location URL: https://karger.com/dee/article-pdf/2/1/343/2563357/000341782.pdfCitation Count: 35
- LRRK2 functions as a Wnt signaling scaffold, bridging cytosolic proteins and membrane-localized LRP62012RESTRICTEDTitle: LRRK2 functions as a Wnt signaling scaffold, bridging cytosolic proteins and membrane-localized LRP6Journal Name: Human Molecular GeneticsPublisher: Oxford University Press (OUP)Vol: 21Issue #: 22Start Page: 4966End Page: 4979Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-ncDOI - Digital Object Identifier: 10.1093/hmg/dds342Best OA location URL: https://academic.oup.com/hmg/article-pdf/21/22/4966/17257652/dds342.pdfCitation Count: 91
-
RESTRICTEDTitle: Large-scale replication and heterogeneity in Parkinson disease genetic lociJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 79Issue #: 7Start Page: 659End Page: 667Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/wnl.0b013e318264e353Best OA location URL: https://europepmc.org/articles/pmc3414661?pdf=renderCitation Count: 123
-
RESTRICTEDTitle: Förster Resonance Energy Transfer (FRET) Correlates of Altered Subunit Stoichiometry in Cys-Loop Receptors, Exemplified by Nicotinic α4β2Journal Name: International Journal of Molecular SciencesPublisher: MDPI AGVol: 13Issue #: 8Start Page: 10022End Page: 10040Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3390/ijms130810022Best OA location URL: https://www.mdpi.com/1422-0067/13/8/10022/pdf?version=1403144658Citation Count: 21
-
RESTRICTEDTitle: Evidence-based guideline: Pharmacologic treatment of chorea in Huntington disease [RETIRED]Journal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 79Issue #: 6Start Page: 597End Page: 603Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/wnl.0b013e318263c443Best OA location URL: https://n.neurology.org/content/neurology/79/6/597.full.pdfCitation Count: 136
-
RESTRICTEDTitle: Increased PK11195 PET binding in the cortex of patients with MS correlates with disabilityJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 79Issue #: 6Start Page: 523End Page: 530Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/wnl.0b013e3182635645Best OA location URL: https://europepmc.org/articles/pmc3413767?pdf=renderCitation Count: 157
-
RESTRICTEDTitle: Neurotoxin‐induced selective ubiquitination and regulation of MEF2A isoform in neuronal stress responseJournal Name: Journal of NeurochemistryPublisher: WileyVol: 122Issue #: 6Start Page: 1203End Page: 1210Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1111/j.1471-4159.2012.07860.xBest OA location URL: https://europepmc.org/articles/pmc4135048?pdf=renderCitation Count: 17
-
RESTRICTEDTitle: Genomic determinants of motor and cognitive outcomes in Parkinson’s diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 18Issue #: 7Start Page: 881End Page: 886Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2012.04.025Best OA location URL: https://europepmc.org/articles/pmc3606821?pdf=renderCitation Count: 28
-
RESTRICTEDTitle: Pathophysiology of manganese-associated neurotoxicityJournal Name: NeuroToxicologyPublisher: Elsevier BVVol: 33Issue #: 4Start Page: 881End Page: 886Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neuro.2011.12.010Best OA location URL: https://europepmc.org/articles/pmc3350837?pdf=renderCitation Count: 112
-
RESTRICTEDTitle: Stress-Induced Phosphorylation and Proteasomal Degradation of Mitofusin 2 Facilitates Mitochondrial Fragmentation and ApoptosisJournal Name: Molecular CellPublisher: Elsevier BVVol: 47Issue #: 4Start Page: 547End Page: 557Publication Date:Open Access(OA) Status: RESTRICTEDLicense: elsevier-specific: oa user licenseDOI - Digital Object Identifier: 10.1016/j.molcel.2012.05.041Best OA location URL: http://www.cell.com/article/S1097276512004868/pdfCitation Count: 280
-
RESTRICTEDTitle: The PRIPS study: screening battery for subjects at risk for Parkinson's diseaseJournal Name: European Journal of NeurologyPublisher: WileyVol: 20Issue #: 1Start Page: 102End Page: 108Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1111/j.1468-1331.2012.03798.xCitation Count: 113
-
RESTRICTEDTitle: Protein disulfide isomerases in neurodegeneration: From disease mechanisms to biomedical applicationsJournal Name: FEBS LettersPublisher: WileyVol: 586Issue #: 18Start Page: 2826End Page: 2834Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.febslet.2012.07.023Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1016/j.febslet.2012.07.023Citation Count: 85
-
RESTRICTEDTitle: Ranbp2 haploinsufficiency mediates distinct cellular and biochemical phenotypes in brain and retinal dopaminergic and glia cells elicited by the Parkinsonian neurotoxin, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)Journal Name: Cellular and Molecular Life SciencesPublisher: Springer Science and Business Media LLCVol: 69Issue #: 20Start Page: 3511End Page: 3527Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1007/s00018-012-1071-9Best OA location URL: https://link.springer.com/content/pdf/10.1007/s00018-012-1071-9.pdfCitation Count: 29
-
RESTRICTEDTitle: Polymorphisms in the glial glutamate transporter SLC1A2 are associated with essential tremorJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 79Issue #: 3Start Page: 243End Page: 248Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/wnl.0b013e31825fdeedBest OA location URL: https://europepmc.org/articles/pmc3398434?pdf=renderCitation Count: 107
-
RESTRICTEDTitle: The MAPT H1 haplotype is associated with tangle-predominant dementiaJournal Name: Acta NeuropathologicaPublisher: Springer Science and Business Media LLCVol: 124Issue #: 5Start Page: 693End Page: 704Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s00401-012-1017-1Best OA location URL: https://europepmc.org/articles/pmc3608475?pdf=renderCitation Count: 73
-
RESTRICTEDTitle: Disease progress and response to treatment as predictors of survival, disability, cognitive impairment and depression in Parkinson's diseaseJournal Name: British Journal of Clinical PharmacologyPublisher: WileyVol: 74Issue #: 2Start Page: 284End Page: 295Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1111/j.1365-2125.2012.04208.xBest OA location URL: https://europepmc.org/articles/pmc3630748?pdf=renderCitation Count: 41
- Progression of motor and nonmotor features of Parkinson's disease and their response to treatment2012RESTRICTEDTitle: Progression of motor and nonmotor features of Parkinson's disease and their response to treatmentJournal Name: British Journal of Clinical PharmacologyPublisher: WileyVol: 74Issue #: 2Start Page: 267End Page: 283Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1111/j.1365-2125.2012.04192.xBest OA location URL: https://europepmc.org/articles/pmc3630747?pdf=renderCitation Count: 148
-
RESTRICTEDTitle: Serotonin transporter inhibition attenuates l‐DOPA‐induced dyskinesia without compromising l‐DOPA efficacy in hemi‐parkinsonian ratsJournal Name: European Journal of NeurosciencePublisher: WileyVol: 36Issue #: 6Start Page: 2839End Page: 2848Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1111/j.1460-9568.2012.08202.xBest OA location URL: https://europepmc.org/articles/pmc3445783?pdf=renderCitation Count: 70
-
RESTRICTEDTitle: Pharmacological Rescue of Mitochondrial Deficits in iPSC-Derived Neural Cells from Patients with Familial Parkinson’s DiseaseJournal Name: Science Translational MedicinePublisher: American Association for the Advancement of Science (AAAS)Vol: 4Issue #: 141Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1126/scitranslmed.3003985Best OA location URL: https://europepmc.org/articles/pmc3462009?pdf=renderCitation Count: 457
-
RESTRICTEDTitle: Animal models of Parkinson's disease: Limits and relevance to neuroprotection studiesJournal Name: Movement DisordersPublisher: WileyVol: 28Issue #: 1Start Page: 61End Page: 70Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.25108Best OA location URL: https://europepmc.org/articles/pmc3517687?pdf=renderCitation Count: 162
-
RESTRICTEDTitle: Daytime alertness in Parkinson's disease: Potentially dose‐dependent, divergent effects by drug classJournal Name: Movement DisordersPublisher: WileyVol: 27Issue #: 9Start Page: 1118End Page: 1124Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.25082Best OA location URL: https://europepmc.org/articles/pmc3589103?pdf=renderCitation Count: 43